Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03378557
Other study ID # PPFx
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 31, 2018
Est. completion date March 31, 2027

Study information

Verified date March 2024
Source AO Innovation Translation Center
Contact Cynthia Sob
Phone +41 79 893 74 28
Email cynthia.sob@aofoundation.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.


Description:

To close the gap of missing clinical evidence regarding the treatment of periprosthetic fractures after arthroplasty of the hip or the knee with osteosynthesis. To drive further study hypotheses and to answer unforeseen questions. Main questions to be answered by the registry include (but are not exclusive) the following: 1. Influence of implants on outcome 2. Influence of surgical techniques on outcome 3. Influence of bone grafting on outcome 4. Identification of risk factors for failure 5. Identification of postoperative rehabilitation programs and its possible influence on the outcome 6. Influence of fracture type on outcome 7. To serve as a comparative dataset for future studies with improved implants and techniques


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date March 31, 2027
Est. primary completion date January 31, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years - Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring - osteosynthesis alone or - component revision plus plate/nail osteosynthesis - Informed consent obtained, i.e.: - Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form - Signed and dated EC / IRB approved written informed consent - Ability to attend post-operative follow up visits Exclusion Criteria: - Pregnancy or women planning to conceive within the study period - Prisoner

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium Universitaire Ziekenhuiven Leuven Leuven
Colombia Hospital Santa Clara Bogotá
Germany Charité Universitätsmedizin Berlin Berlin
Germany BG-Unfallklinik Ludwigshafen Ludwigshafen
Germany Universitätsklinikum Münster Münster
Spain Hospital Universitario Son Llàtzer Palma De Mallorca
Switzerland Universitätsspital Basel Basel
Switzerland Kantonspital Baselland Liestal
Switzerland Universitätsspital Zürich Zürich
United States University of Missouri Health Care Columbia Missouri
United States Jersey City Medical Center RWJ Barnabas Health Jersey City New Jersey
United States Saint Barnabas Medical Center Livingston Livingston New Jersey
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
AO Innovation Translation Center

Countries where clinical trial is conducted

United States,  Belgium,  Colombia,  Germany,  Spain,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Classification of the fracture Classification of the fracture using the UCS and some parts of the AO/OTA fracture classification system. Pre-operatively (Day -1)
Secondary Fracture mechanism High / low energy trauma, pathological fracture, stem stability Pre-operatively (Day -1)
Secondary Rehabilitation program weight bearing, bedrest, splint Up to 12 months
Secondary Function of hip or knee Harris Hip Score or Knee Society score Up to 12 months
Secondary Health related quality of life PROMIS pain interference and physical activity Up to 12 months
Secondary Fracture healing by RUSH or RUST score Up to 12 months
Secondary pain visual analog scale (VAS) and pain medication Using the pain visual analog scale (VAS) and pain medication Up to 12 months
See also
  Status Clinical Trial Phase
Completed NCT03326271 - Postoperative Periprosthetic Fractures in Hip Fracture Patients: Exeter vs Anatomic SP2 Lubinus Stem
Recruiting NCT01973712 - Periprosthetic Distal Femur Fracture N/A
Not yet recruiting NCT03358186 - Investigation on the Surgical Treatment Effect of Periprosthetic Femur Fracture After Hip Arthroplasty N/A
Recruiting NCT06028971 - Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case Series
Completed NCT02391129 - Locking Compression Plate Fixation Versus Revision- Prosthesis of Vancouver-B2, B3 and C Periprosthetic Femoral Fractures After Total Hip Replacement N/A
Recruiting NCT04663893 - Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
Recruiting NCT03312088 - Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship